Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

TransMedics (TMDX) Accumulated Depreciation & Amortization (2018 - 2025)

Historic Accumulated Depreciation & Amortization for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $60.6 million.

  • TransMedics' Accumulated Depreciation & Amortization rose 7190.12% to $60.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.6 million, marking a year-over-year increase of 7190.12%. This contributed to the annual value of $40.7 million for FY2024, which is 9120.84% up from last year.
  • Latest data reveals that TransMedics reported Accumulated Depreciation & Amortization of $60.6 million as of Q3 2025, which was up 7190.12% from $53.8 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Accumulated Depreciation & Amortization registered a high of $60.6 million during Q3 2025, and its lowest value of $9.7 million during Q4 2021.
  • For the 5-year period, TransMedics' Accumulated Depreciation & Amortization averaged around $32.2 million, with its median value being $30.0 million (2024).
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first skyrocketed by 2127.82% in 2021, then surged by 9959.22% in 2024.
  • Quarter analysis of 5 years shows TransMedics' Accumulated Depreciation & Amortization stood at $9.7 million in 2021, then skyrocketed by 34.86% to $13.1 million in 2022, then skyrocketed by 62.18% to $21.3 million in 2023, then surged by 91.21% to $40.7 million in 2024, then soared by 48.79% to $60.6 million in 2025.
  • Its Accumulated Depreciation & Amortization was $60.6 million in Q3 2025, compared to $53.8 million in Q2 2025 and $46.9 million in Q1 2025.